Live Breaking News & Updates on Applied Therapeutics To Host Virtual Rare Disease Forum Mar 16

Published: Mar 16, 2021
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE)
Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it will host a Virtual Rare Disease Forum on Tuesday, March 23
rd, 2021 from 1:00pm to 3:00pm ET. The event will highlight Applied Therapeutics’ development programs in Galactosemia, SORD Deficiency, and PMM2-CDG. The agenda for the event will include:
Update on ACTION-Galactosemia Clinical Development Program
Overview of SORD Deficiency, presented by Stephan L. Züchner, MD, PhD, Professor and Department Chair of Human Genetics at the University of Miami Miller School of Medicine ....

United States , Joseph Muenzer , Maeve Conneighton , Shoshana Shendelman , University Of North Carolina Children Research Institute , Clinical Development Program , Virtual Rare Disease Forum On , University Of Miami Miller School Medicine , Deficiency Clinical Development , Therapeutics Inc , Virtual Rare Disease Forum , Applied Therapeutic , Galactosemia Clinical Development , Department Chair , Human Genetics , Miami Miller School , Clinical Development , Pediatric Genetics , North Carolina Children , Development Program , Diabetic Cardiomyopathy , Applied Therapeutics To Host Virtual Rare Disease Forum Mar 16 , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினா குழந்தைகள் ஆராய்ச்சி நிறுவனம் , மருத்துவ வளர்ச்சி ப்ரோக்ர்யாம் , மெய்நிகர் ரேர் நோய் மன்றம் ஆன் ,